Cvs Pharmacy #16594 Durable Medical Equipment & Medical Supplies Location: 356 12th St Sw, Forest Lake, Minnesota 55025 Phone: (651) 464-1994 |
Walgreens #7111 Durable Medical Equipment & Medical Supplies Location: 1207 W Broadway Ave, Forest Lake, Minnesota 55025 Phone: (651) 255-1887 |
Wal-mart Pharmacy 10-2274 Durable Medical Equipment & Medical Supplies Location: 200 12th St Sw, Forest Lake, Minnesota 55025 Phone: (651) 464-9742 |
Thrifty White Pharmacy #773 Community/Retail Pharmacy Location: 1420 Lake St S, Forest Lake, Minnesota 55025 Phone: (651) 464-5518 |
Cub Pharmacy #1634/693 Durable Medical Equipment & Medical Supplies Location: 2013 W Broadway Ave, Forest Lake, Minnesota 55025 Phone: (651) 982-4603 |
Rolseth Drug Co Long Term Care Pharmacy Location: 107 Lake St N, Forest Lake, Minnesota 55025 Phone: (651) 464-2114 |
Power Chairs And Scooter Store DME Supplier - Customized Equipment Location: 255 Highway 97, Forest Lake, Minnesota 55025 Phone: (651) 982-0002 |
Rossodontics Dental Sleep Medicine Medicare Supplier Location: 368 Lake St S, Forest Lake, Minnesota 55025 Phone: (651) 464-6988 |
News Archive
Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and The Ohio State University Wexner Medical Center are conducting a new clinical trial to determine if an oral cancer drug called ibrutinib can also help patients with cancer or other immunocompromised conditions recover from COVID-19.
A new Global Health Security Index released today, the first comprehensive assessment and benchmarking of health security and related capabilities across 195 countries, suggests that not a single country in the world is fully prepared to handle an epidemic or pandemic.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted EYLEA (aflibercept) Injection Breakthrough Therapy designation for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME).
"We made solid product development progress this quarter," commented Mark H.N. Corrigan, MD, President and CEO of Zalicus. "We finalized our development plans for Synavive, and also related to Synavive, we were awarded a Therapeutic Discovery Project grant to help fund Synavive development going forward.
› Verified 2 days ago